| mTOR inhibitors: Temsirolimus and everolimus in the treatment of renal cell ... - UroToday |
|
|
UroTodayTemsirolimus has shown in a randomized phase III trial for patients with poor risk feature of metastatic renal cell carcinoma, a significant gain in overall ... read more |